School of Law

Centre for Intellectual Property Rights Studies (CIPRS)

Fostering innovation, legal excellence, research and interdisciplinary collaboration in Intellectual Property Rights.

CIPRS Logo

About the Centre

The Centre for Intellectual Property Rights Studies (CIPRS), School of Law, SGT University, aims to emerge as a premier institution for IPR education and research in India and a globally recognized platform for learning, research, and collaboration. The Centre is committed to promoting quality education, training, and awareness in IPR through academic programmes, seminars, workshops, and interdisciplinary research.

It strives to contribute to the development of IP policies and laws, foster innovation and creativity, and provide legal and technical support for intellectual property protection and commercialization. The Centre also seeks to maintain a balance between the rights of creators and the public interest in ensuring affordable access to knowledge, innovations, and creative works, thereby contributing to economic development and societal progress.

The centre provides a platform for learning, research and collaboration in the field of IPR. Also to foster a culture of innovation and creativity in SGT University by providing the necessary legal and technical support for IP protection and commercialization.

At a Glance

  • 📌 Institution: School of Law, SGT University
  • 📌 Core Focus: Patents, Copyrights, Trademarks, AI & IPR
  • 📌 Director: Ms. Tripti Bhushan
  • 📌 Email: [email protected]
👁️

Our Vision

To emerge as a premier institution shaping the future of intellectual property rights education and research in India, and a globally reputed platform for learning, research and collaboration in the field of IPR focusing on the advancement of IP knowledge and practice, with the broader goals of economic development and societal progress.

🎯

Our Mission

  • To provide a platform for learning, research and collaboration in the field of IPR.
  • To carry out legal and interdisciplinary research initiatives in the area of IPR and contribute to the formulation and improvement of IP policies and laws at national and international levels.
  • Promote a balance between creators’ rights and the public interest in accessing knowledge and innovation.

Objectives and Functions

1. Education & Training

To provide high-quality education and training in IPR to students, legal practitioners, and industry professionals.

2. Awareness Programmes

Promote IPR awareness through academic activities, seminars, workshops, and conferences.

3. Specialized Courses

Offer specialized IPR courses, diplomas, certificates, and support IPR curriculum development.

4. Dissemination & Advisory

Disseminate IPR knowledge through publications and provide advisory support to inventors, artists, and entrepreneurs.

5. Interdisciplinary Research

Undertake interdisciplinary IPR research and collaborate with academic institutions, research organisations, and industry.

6. Culture of Innovation

Foster a culture of innovation and creativity in SGT University by providing legal and technical support for IP protection and commercialization.

7. Policy & Law Development

Contribute to the development of national and international IP policies and laws.

8. Resource Toolkits

Preparation of Resource toolkits for different levels of Intellectual Property Right Courses.

Director's Message

Ms. Tripti Bhushan

Ms. Tripti Bhushan

Director, CIPRS

Faculty of Law, SGT University

[email protected]

View Full Profile

It is my privilege to lead the Centre for Intellectual Property Rights Studies (CIPRS), Faculty of Law, SGT University, with a commitment to promoting excellence in intellectual property education, research, and practice. In an era of rapid technological advancement and growing innovation, intellectual property rights play a vital role in protecting creativity, encouraging innovation, and facilitating knowledge sharing. Through the Centre, we aim to create a dynamic platform for students, academicians, researchers, legal practitioners, and industry professionals to engage with contemporary and emerging issues in IPR.

Our focus is to foster interdisciplinary research, provide meaningful learning opportunities, and promote collaboration among academic institutions, industry, and other stakeholders. We aspire to nurture a culture of innovation and creativity while ensuring a balanced approach between the protection of creators’ rights and the larger public interest. Through seminars, workshops, training programmes, research initiatives, and collaborative activities, CIPRS seeks to contribute to the development of intellectual property knowledge and practice at both national and international levels.

"I invite students, scholars, professionals, and all those interested in intellectual property to join us in this journey of learning, research, and innovation. Together, we can strengthen the culture of intellectual property awareness and contribute towards a more creative, inclusive, and knowledge-driven society."

Core Team Members

Ms Rimika Rajput

Ms. Rimika Rajput

Additional Director

[email protected]

LL.M. in IPR under WIPO/NLUD/IPO Programme (AIR 46 AILET'25). Registered Trademark Attorney with Govt. of India. Member of WIPO-ADR-YOUNG with expertise in trademark, patent law and IP policy research.

Ms. Vidhi

Ms. Vidhi

Research & Publication Lead

Leading research publications, academic papers and student research initiatives at CIPRS.

Mr Samrat Singh

Mr. Samrat Singh

Social Media & Outreach Lead

Managing public relations, social media outreach and community engagement for CIPRS events.

Student Coordinators

Ms. Niti Rani

Ms. Niti Rani

Student Coordinator

Mr. Divyansh Yadav

Mr. Divyansh Yadav

Student Coordinator

Ms. Anshul Yadav

Ms. Anshul Yadav

Student Coordinator

Mr. Ashish Yadav

Mr. Ashish Yadav

Student Coordinator

News & Events

Lectures, Workshops, Certificate Courses and Competitions

Year 2026 - Key Initiatives CIPRS 2026
30 September 2026

Expert Lecture: "The Copyright vis-à-vis AI Dilemma: Authorship, Fair Use, and the Future of Creativity"

Speaker: Dr. Debmita Mondal, Assistant Professor (Senior Scale) of Law, Hidayatullah National Law University, Raipur.

9th October 2026

Guest Lecture: "AI and IPR Rights: Global Challenges and Emerging Questions and the Future of Innovation"

Speaker: Dr. Divita Kothekar, Assistant Professor of Law, Maharashtra National Law University, Nagpur.

22nd & 23rd October 2026

Two-Day Workshop: "From Ideas to Intellectual Assets: Understanding, Protecting and Building a Career in Intellectual Property"

Resource Person: Dr. Anchit Verma, Assistant Professor & Deputy Registrar (Admin), MNLU Nagpur.

3rd, 10th, 17th, 24th Oct 2026

Certificate Course: "Mediation in Intellectual Property Rights"

Launched by Centre for Intellectual Property Rights Studies (CIPRS).

Upcoming 14th November 2026

Guest Lecture: "IP, Cybersecurity and Data: The DPDP Act Interplay"

Speaker: Ms. Panya Sethi, Management Trainee, Vastu Housing Finance Corporation.

Upcoming 25th November 2026

Academic Interaction: "Beyond the Law Books: Building a Career in IPR Law and Thriving in Law Firms"

Speaker: Advocate Sakshi Agarwal, Founder, Chanakshi Consultants.

🏆 1st Essay Competition 2026

Theme: "AI, Human Identity and Creative Rights: Reconciling Copyright, Voice Cloning, Consent and Compensation with the Right to Identity and Human Dignity"

Ongoing Event

🌾 Certificate Course 2025

Course: "Intellectual Property Rights in Agriculture"
Dates: 4th April, 18th April, 25th April, 2nd May, 6th May 2025.

Call for Blogs & Featured Articles

Insights and legal analysis on contemporary Intellectual Property Rights issues

Patent Evergreening
Patents & Healthcare

From Patent Evergreening to Public Health: The Indian Dilemma of Innovation versus Access

By Kalpita Chaudhary, BCom LLB (3rd Year), Jindal Global Law School

The purpose of patent law is to provide a monopoly to the inventor for a limited period to encourage invention... Patent evergreening is a set of tactics used to gain further monopoly rights through minor modifications.

The purpose of patent law is to provide a monopoly to the inventor for a limited period of time to encourage invention and innovation, to see that innovation ultimately serves society's interests. However, in the pharmaceutical sector this balance takes on a special meaning, as the longer a patent is protected, the more likely a medicine is to be unavailable and more expensive, or to be unavailable at all. Patent evergreening is a set of tactics that can be used by a patent holder to gain further term of monopoly rights by filing patents for relatively insignificant modifications of an existing product, even if they offer no significant therapeutic advantages. The key is to separate true incremental innovation from an effort to extend monopoly protection.

This balancing of these interests is evident in the Indian patent regime. India's generic pharmaceutical industry developed due to the Patents Act, 1970 which did not cover product patents for pharmaceutical substances. The duty under the TRIPS Agreement led to the inclusion of product patent protection in the amendment, culminating in the 2005 amendment. The introduction of Section 3(d) into Parliament was to avoid the patenting of new forms or derivatives of known substances unless they can be shown to provide improved therapeutic effects. It also renders ineligible for patenting any new use of substances already known.

Novartis AG v Union of India was a case that was focused on the interpretation of Section 3(d). Novartis has applied for patents on the beta crystalline form of imatinib mesylate which is linked to Gleevec. The Supreme Court decided that the claimed form was not the same as the form that enjoyed the benefits of the statutory requirement of improved therapeutic effect. The ruling set a high bar for secondary pharmaceutical patents and strengthened Section 3(d) as a protection against "evergreening”. Concurrently, the judgment acknowledged that member states have a certain degree of discretion as to what constitutes patentability under TRIPS. Even with this protection, Section 3(d) is difficult to interpret. The bill doesn't specify a specific quantifiable amount of increased efficacy; instead, patent examiners and courts will decide whether the standard is met. This flexibility can cause confusion for innovators in the pharmaceutical field, especially in cases of incremental changes that offer significant safety, stability, dosage, and therapeutic benefits. Another challenge is that there may be clinical evidence showing a therapeutic benefit after the filing deadline.

The Indian approach can also be compared markedly to the models of the United States and Europe which are being used today. Secondary patents are mainly dealt with in the United States through the doctrines of non-obviousness, double patenting and the Hatch-Waxman framework which promotes generic competition. European practice takes a different approach, allowing for protection of some new therapies, but not repeated monopolization of existing products. Evergreening is not restricted to Section 3(d). Under Section 107A (the Bolar exception), generic manufacturers can engage in activities prior to the expiration of a patent that are needed to obtain regulatory approval. This is a mechanism to avoid the unnecessary delay in generic market entry due to regulatory delays. European patent practice similarly permits protection for certain genuine pharmaceutical innovations, including particular formulations and therapeutic applications where the relevant legal requirements are satisfied. However, European systems also contain mechanisms designed to prevent repeated or unjustified extension of patent rights. The comparative experience demonstrates that there is no single universal solution to the problem of pharmaceutical evergreening. Different jurisdictions attempt to balance innovation and access through different combinations of patentability standards, examination practices, regulatory mechanisms, and generic competition.

The broader debate surrounding patent evergreening therefore raises a fundamental question: How much exclusivity is necessary to encourage pharmaceutical innovation, and at what point can additional exclusivity begin to undermine public access? There is no simple answer. Pharmaceutical research requires substantial financial investment and carries considerable scientific and commercial risk. Strong intellectual property protection can provide companies with incentives to invest in the development of new medicines. At the same time, excessively broad or repeatedly extended protection can limit competition and affect the affordability and availability of medicines, particularly in developing countries. For India, the objective should therefore not be to choose between innovation and access, but to design a legal framework in which the two can coexist. A clearer and more transparent approach to assessing enhanced efficacy, stronger patent examination and opposition mechanisms, greater regulatory coordination, and incentives for genuine incremental pharmaceutical research could help achieve this balance. Ultimately, patent law should reward real innovation rather than merely prolonged exclusivity. The Indian experience demonstrates that pharmaceutical patent policy has consequences far beyond the patent system itself. It affects researchers, pharmaceutical companies, generic manufacturers, healthcare institutions, and, most importantly, patients. The challenge for Indian patent law is thus to maintain an equilibrium in which inventors receive meaningful protection for genuine contributions while society retains access to affordable medicines. The future of pharmaceutical patent policy will depend on maintaining this delicate balance—ensuring that the patent system remains an engine of innovation without becoming a barrier to public health.

IPRS v Hotel Appolo
Copyright & Broadcasting

IPRS v Hotel Appolo & Tours: How a Narrow Reading of “Subscriber” Tests the Line on Communication to the Public

By Taskin Akhtar & Sarbeswar Mishra, B.A. LL.B. (3rd Year), NUSRL Ranchi

Analysing the Calcutta High Court’s decision holding that a hotel relaying cable TV to guest rooms communicates copyrighted works to the public and needs a licence from IPRS.

The hotel provided cable service to guest rooms without obtaining a public performance license. Under Explanation to Section 2(ff) of the Copyright Act, 1957, transmission to multiple hotel rooms constitutes communication to the public.

The Supreme Court stayed the High Court judgment in August 2026, leaving the licensing chain open for final resolution.

Generative AI
Artificial Intelligence & Law

Generative AI and Copyright Infringement: Navigating the “Training Data” Conundrum

By Md Sahidullaha, LL.M. Candidate, HPNLU Shimla

Generative AI tools require massive datasets for training. Does using copyrighted works without consent amount to infringement?

Examining ANI Media Pvt. Ltd. v. OpenAI OpCo LLC before the Delhi High Court and India's Working Paper on "One Nation One License One Payment". India needs a balanced framework anchored in transparency, lawful access, and reasonable remuneration for creators.

Dupe Economy
Fashion & Design Law

The Dupe Economy: Fashion Design Piracy and the Limits of IP Protection in India

By Aradhya Singh, LLM (2nd Year), Meerut College

The rapid imitation of luxury fashion designs in fast fashion raises critical questions regarding the Designs Act, 2000 and Section 15 of the Copyright Act, 1957.

Under Section 15(2) of the Copyright Act, copyright in an unregistered design ceases once reproduced more than 50 times by an industrial process. India needs streamlined design registration to protect independent creators.

Event Highlights & Posters

Glimpses of CIPRS expert sessions, workshops and academic competitions

Poster 1
Poster 2
Poster 3
Poster 4

Contact Us

Centre for Intellectual Property Rights Studies (CIPRS)

School of Law, SGT University, Chandu-Budhera, Gurugram–Badli Road, Gurugram, Haryana 122505

We're here to help you shape the future.

CONTACT US
Complete Online Registration